Brawn Biotech Ltd.
BSE: 530207 | Sector: Others |
NSE: N.A. | ISIN Code: INE899B01015 |
BSE 00:00 | 01 Mar | 24.80 |
0 (0.00%) |
OPEN
23.90 |
HIGH
25.40 |
LOW
23.60 |
NSE 05:30 | 01 Jan | Brawn Biotech Ltd |
OPEN | 23.90 |
PREVIOUS CLOSE | 24.80 |
VOLUME | 382 |
52-Week high | 32.00 |
52-Week low | 16.95 |
P/E | |
Mkt Cap.(Rs cr) | 7 |
Buy Price | 23.60 |
Buy Qty | 90.00 |
Sell Price | 24.80 |
Sell Qty | 218.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Brawn Biotech Ltd. (BRAWNBIOTECH) - Nine Monthly Result
Particulars (![]() |
Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 |
Net Sales/Income From Operations | 31.91 | 42.95 | 49.75 | 39.31 | 44.10 |
Other Income | 0.00 | 0.06 | 0.14 | 0.57 | 0.58 |
Total Income | 31.91 | 43.01 | 49.90 | 39.88 | 44.68 |
Total Expenditure | 31.82 | 41.75 | 48.39 | 38.19 | 43.10 |
Operating Profit | 0.09 | 1.26 | 1.51 | 1.69 | 1.58 |
Interest | 0.02 | 0.03 | 0.04 | 0.02 | 0.02 |
Gross Profit | 0.08 | 1.23 | 1.47 | 1.67 | 1.56 |
Depreciation | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 |
PBT | 0.05 | 1.20 | 1.45 | 1.65 | 1.54 |
Tax | 0.00 | 0.29 | 0.42 | 0.53 | 0.38 |
Net Profit/(Loss) | 0.05 | 0.91 | 1.03 | 1.12 | 1.16 |
Minority Interest After NP | - | - | - | - | - |
Net Profit after Minority Interest | - | - | - | - | - |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.58 |
Profit After Exceptional Items | 0.05 | 0.91 | 1.03 | 1.12 | 0.58 |
Equity Share Capital | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 |
Reserves Excluding Revaluation Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 3.69 |
EPS | |||||
Basic EPS | -0.05 | 2.81 | 3.61 | 3.61 | 3.87 |
Public Share Holding | |||||
No Of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
Share Holding (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Promoters and Promoter Group Shareholding | |||||
a) Pledged/Encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of Shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of Shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
b) Non-encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Note : | PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure. |
Quick Links for Brawn Biotech:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices